#chemotherapy — Thursday, July 09, 2026 (1 items)
| 0 | 💬 0 |
KRAS-G12D inhibitor HRS-4642 plus chemotherapy in advanced KRAS(G12D)-mutant pancreatic cancer: a phase 1b/2 trial.
(nature.com)
|
Nature Medicine 2026-07-09 | #oncology #pancreatic cancer #clinical trial #targeted therapy #chemotherapy |